THRV-1268

N/A

Report date: 2024/07/19 17:54:34
NME

Base Information

Drug NameTHRV-1268
Drug Alias NameTHRV-1268
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Sgk1 inhibitors
TargetsSerine/threonine-protein kinase Sgk1
Therapy Area/IndicationsHeart FailureAtrial Fibrillation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThryv Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesThryv Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHeart FailureAtrial Fibrillation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A